| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a48b04f986c44c2ca9129ce0b1d17c6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586ca39cbe8d8301533e6e020fe07030 |
| publicationDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6759041-B1 |
| titleOfInvention |
Preventives/remedies for autoimmune demyelinating diseases |
| abstract |
The present invention is drawn to a method for treating autoimmune demyelinating diseases by administering to a patient in need thereof an effective amount of a Fas antagonist. The method of the present invention uses, for example, as a Fas antagonist a substance which suppresses Fas-Fas ligand binding. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007255455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7848848-B2 |
| priorityDate |
1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |